Clinically, the incidence of hemorrhoid-prostatic hyperplasia syndrome (HP), i.e., prostatic hyperplasia (BPH) with hemorrhoids, is high among patients seen for hemorrhoids, usually mostly in middle-aged and older men over 40 years of age, but with clinical reports in the past few years, there is a trend toward younger age of the disease. Some patients have impotence, i.e. hemorrhoid-prostate hypertrophy-impotence syndrome (HPI). Patients with HPI can often be seen in either anorectal or urological departments at the same time, so reports on its incidence vary, with the former reporting 1%-3% and the latter up to 95% or more. The former is reported as 1 to 3 percent, while the latter is reported as high as 95 percent or more. Internal hemorrhoids are more severe in anorectal patients, mostly severe III or mixed hemorrhoids; while in urological patients, internal hemorrhoids are generally less symptomatic. The etiology of hemorrhoids with prostate enlargement or impotence is not yet fully understood, and may be related to anatomical factors, hormonal factors, etc. The treatment of hemorrhoids with prostatic hyperplasia or impotence used to be carried out by the anorectal and urological departments respectively, with different treatments due to unknown causes. The Chinese medicine focuses on a holistic concept, “diagnosis and treatment”, using Chinese herbal medicine as a whole, while supplementing with sex hormone therapy, injection therapy and surgery according to the severity of the symptoms, in order to “prevent the disease from changing and the disease from recovering”.